Posted by Michael Wonder on 25 Aug 2016
Another drug pricing ripoff
24 August 2016 - New York Times comments on the current EpiPen pricing furore.
The rapid increase in the price of the EpiPen, a device used to give an injection that can save people from deadly allergic reactions, has shocked consumers and lawmakers.
Yet it is just one more outrageous instance of pharmaceutical companies raising prices for lifesaving medicines with no justification other than the desire to increase profits — and doing so knowing that government can do little about it.
